Blog Posts
Find blog posts shared by the Owlstown community.
What is it like attending a conference as a PhD student?
Back in August, I attended the 31st EECERA conference held in Estoril, Portugal. This was my second in-person conference, but it was the first time I would present as part of a symposium group.
After registering at the conference front desk, m...
Post · October 08, 2023
Comment on my bioinformatics paper "The prognostic value of PI3K mutational status in breast cancer: A meta-analysis"
The article was published in the Journal of Cellular Biochemistry in January 2018. The authors of the manuscript are N. Sobhani, G. Roviello, S.P. Corona, M. Scaltriti, A. Ianza, M. Bortul, F. Zanconati, and D. Generali.
The article discusses the...
Post · October 07, 2023
Comment on my co-authored study "Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair"
This article analyzes gene expression and DNA repair status in epithelioid mesothelioma patients to identify potential biomarkers associated with survival outcomes. The key findings were:
- A cohort of 54 epithelioid mesothelioma patients with he...
Post · October 07, 2023
Comment on my NPJ co-authored article "The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma"
Here is a comment on the research article:
This study developed an adenovirus-based vaccine co-encoding the renal cancer antigens CAIX and immune checkpoint PD-L1, and evaluated its therapeutic effects in mouse models of renal carcinoma. The main...
Post · October 07, 2023
Comment on my study "Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report"
The study presented in the article "Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report" explores the expression of PD-L1 and CD3 in glioblastoma patients and their correlation with pa...
Post · October 07, 2023
Comment on my study "Tumour Infiltrating Lymphocytes and PD-L1 Expression as Potential Predictors of Outcome in Patients with Malignant Pleural Mesothelioma"
The paper is an original article published in Molecular Biology Reports in 2019. The study aimed to investigate the correlation between tumour infiltrating lymphocytes (TILs) and programmed cell death ligand 1 (PD-L1) expression with overall survi...
Post · October 07, 2023
Comment on my co-athored study "Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma."
The study aimed to investigate the correlation between the prognosis of pancreatic ductal adenocarcinoma (PDAC) patients and the presence of tumour infiltrating lymphocytes (TILs) and the expression of immune system genes.
The researchers examine...
Post · October 07, 2023
Comment on co-authored study "Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study"
The study explores the association between immune system features and the therapeutic activity of everolimus in hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer (mBC). The researchers aimed to identify potential biomarkers th...
Post · October 07, 2023
Comment on my bioinformatic paper "p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis"
The article focuses on the topic of p53 antibodies (p53 Abs) as a diagnostic marker for cancer and presents a meta-analysis on the prognostic value of p53 Abs in patients with solid tumors.
The article begins by introducing the significance of p5...
Post · October 07, 2023
Comment on my Nature book chapter "Biomarkers of Prediction of Immunotherapy and Updates on CTLA-4 Therapy"
- It provides a comprehensive overview of CTLA-4 inhibition as an immunotherapy approach, including insights into the structure, function, and mechanism of action of CTLA-4. This helps establish foundational knowledge on this important checkpoint ...
Post · October 07, 2023